{"id":69790,"name":"RECORDATI RARE DISEASES INC.","slug":"recordati-rare-diseases-inc","state":"NJ","country":"United States of America","description":"Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.","totalSpending":60000,"filings":2,"yearlySpending":[{"year":2025,"income":60000}],"issues":["HCR","MMM","TRD"],"firms":["ARNOLD & PORTER KAYE SCHOLER LLP"],"lobbyists":["BOBBY MCMILLIN","PETER DUYSHART","VICTORIA DAVILA","EUGENIA PIERSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.","Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.","Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.","Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.","Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies."],"years":[2025]}